vs

Side-by-side financial comparison of Chemours Co (CC) and TEREX CORP (TEX). Click either name above to swap in a different company.

Chemours Co is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.0× TEREX CORP). TEREX CORP runs the higher net margin — 4.8% vs -3.5%, a 8.3% gap on every dollar of revenue. On growth, TEREX CORP posted the faster year-over-year revenue change (6.2% vs -2.1%). TEREX CORP produced more free cash flow last quarter ($171.0M vs $92.0M). Over the past eight quarters, TEREX CORP's revenue compounded faster (1.0% CAGR vs -1.2%).

The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.

Terex Corporation is an American company and worldwide manufacturer of materials processing machinery, waste and recycling equipment, mobile elevating work platforms, and equipment for the electric utility industry. Terex does business in the Americas, Europe, Australia and Asia Pacific.

CC vs TEX — Head-to-Head

Bigger by revenue
CC
CC
1.0× larger
CC
$1.3B
$1.3B
TEX
Growing faster (revenue YoY)
TEX
TEX
+8.3% gap
TEX
6.2%
-2.1%
CC
Higher net margin
TEX
TEX
8.3% more per $
TEX
4.8%
-3.5%
CC
More free cash flow
TEX
TEX
$79.0M more FCF
TEX
$171.0M
$92.0M
CC
Faster 2-yr revenue CAGR
TEX
TEX
Annualised
TEX
1.0%
-1.2%
CC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CC
CC
TEX
TEX
Revenue
$1.3B
$1.3B
Net Profit
$-47.0M
$63.0M
Gross Margin
11.7%
18.8%
Operating Margin
10.4%
Net Margin
-3.5%
4.8%
Revenue YoY
-2.1%
6.2%
Net Profit YoY
-261.5%
2963.6%
EPS (diluted)
$-0.32
$0.95

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CC
CC
TEX
TEX
Q4 25
$1.3B
$1.3B
Q3 25
$1.5B
$1.4B
Q2 25
$1.6B
$1.5B
Q1 25
$1.4B
$1.2B
Q4 24
$1.4B
$1.2B
Q3 24
$1.5B
$1.2B
Q2 24
$1.6B
$1.4B
Q1 24
$1.4B
$1.3B
Net Profit
CC
CC
TEX
TEX
Q4 25
$-47.0M
$63.0M
Q3 25
$46.0M
$65.0M
Q2 25
$-380.0M
$72.0M
Q1 25
$-5.0M
$21.0M
Q4 24
$-13.0M
$-2.2M
Q3 24
$-32.0M
$88.0M
Q2 24
$60.0M
$140.7M
Q1 24
$54.0M
$108.5M
Gross Margin
CC
CC
TEX
TEX
Q4 25
11.7%
18.8%
Q3 25
15.6%
20.3%
Q2 25
17.2%
19.6%
Q1 25
17.3%
18.7%
Q4 24
19.4%
15.9%
Q3 24
19.0%
20.2%
Q2 24
19.8%
23.8%
Q1 24
20.9%
23.0%
Operating Margin
CC
CC
TEX
TEX
Q4 25
10.4%
Q3 25
2.5%
10.1%
Q2 25
-15.4%
8.7%
Q1 25
5.6%
Q4 24
-0.1%
4.2%
Q3 24
-2.1%
10.1%
Q2 24
4.4%
14.0%
Q1 24
5.1%
12.2%
Net Margin
CC
CC
TEX
TEX
Q4 25
-3.5%
4.8%
Q3 25
3.1%
4.7%
Q2 25
-23.5%
4.8%
Q1 25
-0.4%
1.7%
Q4 24
-1.0%
-0.2%
Q3 24
-2.1%
7.3%
Q2 24
3.9%
10.2%
Q1 24
4.0%
8.4%
EPS (diluted)
CC
CC
TEX
TEX
Q4 25
$-0.32
$0.95
Q3 25
$0.31
$0.98
Q2 25
$-2.53
$1.09
Q1 25
$-0.03
$0.31
Q4 24
$-0.07
$-0.03
Q3 24
$-0.22
$1.31
Q2 24
$0.39
$2.08
Q1 24
$0.36
$1.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CC
CC
TEX
TEX
Cash + ST InvestmentsLiquidity on hand
$670.0M
$772.0M
Total DebtLower is stronger
$4.1B
$2.6B
Stockholders' EquityBook value
$250.0M
$2.1B
Total Assets
$7.4B
$6.1B
Debt / EquityLower = less leverage
16.40×
1.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CC
CC
TEX
TEX
Q4 25
$670.0M
$772.0M
Q3 25
$613.0M
$509.0M
Q2 25
$502.0M
$374.0M
Q1 25
$464.0M
$298.0M
Q4 24
$713.0M
$388.0M
Q3 24
$596.0M
$352.0M
Q2 24
$604.0M
$319.3M
Q1 24
$746.0M
$364.9M
Total Debt
CC
CC
TEX
TEX
Q4 25
$4.1B
$2.6B
Q3 25
$4.1B
Q2 25
$4.1B
Q1 25
$4.1B
Q4 24
$4.1B
$2.6B
Q3 24
$4.0B
Q2 24
$4.0B
Q1 24
$4.0B
Stockholders' Equity
CC
CC
TEX
TEX
Q4 25
$250.0M
$2.1B
Q3 25
$274.0M
$2.0B
Q2 25
$228.0M
$2.0B
Q1 25
$566.0M
$1.8B
Q4 24
$571.0M
$1.8B
Q3 24
$643.0M
$2.0B
Q2 24
$714.0M
$1.8B
Q1 24
$753.0M
$1.7B
Total Assets
CC
CC
TEX
TEX
Q4 25
$7.4B
$6.1B
Q3 25
$7.5B
$6.2B
Q2 25
$7.5B
$6.2B
Q1 25
$7.4B
$5.8B
Q4 24
$7.5B
$5.7B
Q3 24
$7.5B
$3.8B
Q2 24
$7.2B
$3.8B
Q1 24
$8.0B
$3.8B
Debt / Equity
CC
CC
TEX
TEX
Q4 25
16.40×
1.23×
Q3 25
14.96×
Q2 25
17.99×
Q1 25
7.18×
Q4 24
7.11×
1.41×
Q3 24
6.20×
Q2 24
5.53×
Q1 24
5.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CC
CC
TEX
TEX
Operating Cash FlowLast quarter
$137.0M
$205.0M
Free Cash FlowOCF − Capex
$92.0M
$171.0M
FCF MarginFCF / Revenue
6.9%
13.0%
Capex IntensityCapex / Revenue
3.4%
2.6%
Cash ConversionOCF / Net Profit
3.25×
TTM Free Cash FlowTrailing 4 quarters
$51.0M
$322.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CC
CC
TEX
TEX
Q4 25
$137.0M
$205.0M
Q3 25
$146.0M
$154.0M
Q2 25
$93.0M
$102.0M
Q1 25
$-112.0M
$-21.0M
Q4 24
$138.0M
$177.0M
Q3 24
$139.0M
$116.4M
Q2 24
$-620.0M
$66.5M
Q1 24
$-290.0M
$-33.9M
Free Cash Flow
CC
CC
TEX
TEX
Q4 25
$92.0M
$171.0M
Q3 25
$105.0M
$130.0M
Q2 25
$50.0M
$78.0M
Q1 25
$-196.0M
$-57.0M
Q4 24
$29.0M
$128.0M
Q3 24
$63.0M
$87.4M
Q2 24
$-693.0M
$42.5M
Q1 24
$-392.0M
$-68.9M
FCF Margin
CC
CC
TEX
TEX
Q4 25
6.9%
13.0%
Q3 25
7.0%
9.4%
Q2 25
3.1%
5.2%
Q1 25
-14.3%
-4.6%
Q4 24
2.1%
10.3%
Q3 24
4.2%
7.2%
Q2 24
-44.6%
3.1%
Q1 24
-28.8%
-5.3%
Capex Intensity
CC
CC
TEX
TEX
Q4 25
3.4%
2.6%
Q3 25
2.7%
1.7%
Q2 25
2.7%
1.6%
Q1 25
6.1%
2.9%
Q4 24
8.0%
3.9%
Q3 24
5.0%
2.4%
Q2 24
4.7%
1.7%
Q1 24
7.5%
2.7%
Cash Conversion
CC
CC
TEX
TEX
Q4 25
3.25×
Q3 25
3.17×
2.37×
Q2 25
1.42×
Q1 25
-1.00×
Q4 24
Q3 24
1.32×
Q2 24
-10.33×
0.47×
Q1 24
-5.37×
-0.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CC
CC

Titanium Technologies$563.0M42%
Thermal And Specialized Solutions$443.0M33%
Advanced Performance Materials$312.0M23%
Other Non-Reportable Segment$12.0M1%

TEX
TEX

Aerials Segment$466.0M35%
Materials Processing Segment$428.0M32%
Materials Processing Equipment$279.0M21%
Specialty Equipment$148.0M11%

Related Comparisons